TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
1. TLSI completed an exchange offer for Preferred Stock. 2. Holders could exchange preferred shares for 3.3 common shares.